January 31, 2022
January 31, 2022 —
Remote UC San Diego School of Medicine study finds brain function boosted by daily exercise in middle-aged and older adults.
January 27, 2022
January 27, 2022 —
Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
January 26, 2022
January 26, 2022 —
Novel trial measured simulated driving performance of persons after cannabis use, revealing sharply differentiated levels of ability and perception of skills.
January 26, 2022
January 26, 2022 —
Transcranial magnetic stimulation offers hope for antidepressant-resistant psychiatric disorders at UC San Diego Health.
January 20, 2022
January 20, 2022 —
National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.
January 20, 2022
January 20, 2022 —
UC San Diego Herbert Wertheim School of Public Health study reports that the more steps taken, and the more intense, the lower the risk of Type 2 diabetes among women 65 and older.
January 18, 2022
January 18, 2022 —
Six University of California campuses, in coordination with two national labs and more than one dozen industry partners, have formed the University of California-National Labs Antiviral Treatments Targeting All Coronaviruses and Key RNA viruses Consortium to prepare for and prevent future pandemics.
January 18, 2022
January 18, 2022 —
The University of California San Diego’s Holocaust Living History Workshop (HLHW) 2021-2022 series continues with five profound events that underscore this year’s theme, “Beyond the Great Silence: The Holocaust in Art, Memory, and Life.”
January 14, 2022
January 14, 2022 —
UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
January 13, 2022
January 13, 2022 —
According to a 2021 World Health Organization report, the global COVID-19 pandemic caused an increase in tuberculosis (TB) deaths – 1.5 million in 2020 versus 1.4 million in 2019 – due to a lack of efficient diagnosis and treatment.
